Carbon monoxide releasing molecules and uses thereof
申请人:Blättler Walter Anton
公开号:US09163044B2
公开(公告)日:2015-10-20
Provided herein are novel carbon-monoxide releasing molecules (CO-RMs) of the Formula (I): and esters, amides, salts, solvates and hydrates thereof; wherein R1 and R2 are as described herein. Also provided are pharmaceutical compositions comprising these compounds, methods of their preparation, and their use in the treatment of liver disease and inflammation.
The Ugi reaction with 2-substituted cyclic imines. Synthesis of substituted proline and homoproline derivatives
作者:Valentine G. Nenajdenko、Anton V. Gulevich、Elizabeth S. Balenkova
DOI:10.1016/j.tet.2006.04.021
日期:2006.6
The Ugi three-component reaction with 2-substituted five-, six-, and seven-membered cyclic imines was investigated. The reaction opens a newroute to substituted proline and homoproline derivatives. It was shown that the method is efficient for the one-step preparation of seminatural dipeptides containing natural amino acid residues, and fragments of substituted proline or pipecolinic acid. The scope
Compounds of the following formula are provided for use with kinases:
wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20170362219A1
公开(公告)日:2017-12-21
Compounds having Formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK3 modulation. All the variables defined herein.